Smallpox antiviral: FDA panel gives OK

SIGA Technologies, Inc. (SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced this week on a favorable outcome of the U.S. Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee meeting on oral TPOXX(R), a small molecule antiviral treatment for smallpox. The panel, ["]

The post Smallpox antiviral: FDA panel gives OK appeared first on Outbreak News Today.